Elzanor (12.5/500mg) 14 Tablets
Empagliflozin 12.5mg and Metformin 500mg for type 2 diabetes.
Elzanor 12.5/500mg is a fixed-dose combination of empagliflozin 12.5mg (SGLT2 inhibitor) and metformin 500mg. Empagliflozin reduces renal glucose reabsorption; metformin reduces hepatic glucose production. Used for type 2 diabetes. Usually one tablet twice daily with meals. Pack of 14 tablets.
Purpose
Treatment of type 2 diabetes mellitus as an adjunct to diet and exercise.
Ingredients
Empagliflozin 12.5mg and Metformin hydrochloride 500mg per tablet.
Warnings
Contraindicated in severe renal impairment, diabetic ketoacidosis. Risk of lactic acidosis. Not for type 1 diabetes.
Side Effects
Genital and urinary tract infections, nausea, diarrhea. Rare: lactic acidosis (metformin), ketoacidosis.
Storage Instructions
Store below 25C in a dry place. Keep in original pack to protect from moisture.
| Brand | Tabros |
| Status | Active |
Related Products
